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ABSTRACT
Objective: To develop and validate a risk scoring tool
to identify those who are at increased risk of chlamydia
infection.
Methods: We used demographic data, sexual
behaviour information and chlamydia positivity results
from more than 45000 individuals who attended
Sydney Sexual Health Centre between 1998 and 2009.
Participants were randomly allocated to either the
development or internal validation data set. Using
logistic regression, we created a prediction model and
weighted scoring system using the development data
set and calculated the odds ratio of chlamydia
positivity for participants in successively higher
quintiles of score. The internal validation data set was
used to evaluate the performance characteristics of the
model for ﬁve quintiles of risk scores including
population attributable risk, sensitivity and speciﬁcity.
Results: In the prediction model, inconsistent condom
use, increased number of sexual partners in last
3 months, genital or anal symptoms and presenting to
the clinic for sexually transmitted infections screening
or being a contact of a sexually transmitted infection
case were consistently associated with increased risk
of chlamydia positivity in all groups. High scores
(upper quintiles) were signiﬁcantly associated with
increased risk of chlamydia infection. A cut-point score
of 20 or higher distinguished a increased risk group
with a sensitivity of 95%, 67% and 79% among
heterosexual men, women and men who have sex with
men (MSM), respectively.
Conclusion: The scoring tool may be included as part
of a health promotion and/or clinic website to prompt
those who are at increased risk of chlamydia infection,
which may potentially lead to increased uptake and
frequency of testing.
INTRODUCTION
Chlamydia infection is highly prevalent in
young heterosexuals and men who have sex
with men (MSM) in Australia, with prevalence
estimates of 3e5% in both populations.
1 2
The majority of chlamydia infections are
asymptomatic. Chlamydia is associated with
sequelae such as pelvic inﬂammatory disease
and infertility in women and proctitis in
men.
3e6 Also in MSM, chlamydia re-infection
of the rectum has been associated with an
increased risk of HIV seroconversion.
7
The number of chlamydia notiﬁcations
continues to increase steadily each year
among MSM and young heterosexual men
and young women in Australia,
8 9 as in many
other countries. A major public health chal-
lenge is therefore to identify individuals at
risk of chlamydia and facilitate testing and
treatment before the development of chla-
mydia sequelae and onward transmission to
To cite: Wand H, Guy R,
Donovan B, et al. Developing
and validating a risk scoring
tool for chlamydia infection
among sexual health clinic
attendees in Australia:
a simple algorithm to identify
those at high risk of
chlamydia infection. BMJ
Open 2011;1:e000005.
doi:10.1136/bmjopen-2010-
000005
< Prepublication history for
this paper is available online.
To view these ﬁles please
visit the journal online (http://
bmjopen.bmj.com).
Received 26 September 2010
Accepted 6 January 2011
This ﬁnal article is available
for use under the terms of
the Creative Commons
Attribution Non-Commercial
2.0 Licence; see
http://bmjopen.bmj.com
1National Centre in HIV
Epidemiology and Clinical
Research, Sydney, New
South Wales, Australia
2Sydney Sexual Health
Centre, Sydney, New South
Wales, Australia
3National Centre in HIV Social
Research, University of New
South Wales, Sydney, New
South Wales, Australia
Correspondence to
Dr Handan Wand;
hwand@nchecr.unsw.edu.au
ARTICLE SUMMARY
Article focus
- The authors created a risk assessment tool that
allows people to estimate their own chlamydia
risk score based on simple non-invasive vari-
ables.
Key messages
- The tool described here will potentially provide
a simple and cost-effective method of identifying
and alerting individuals who would beneﬁt from
chlamydia screening.
- This tool may be included as part of a health
promotion and/or clinic website.
- This tool may potentially lead to increased uptake
and frequency of testing.
Strengths and Limitations
- This is the ﬁrst study to utilize statistical methods
to derive a locally-speciﬁc assessment tool using
12 years of data from more than 45 000 men and
women.
- The Study population was sexual health clinic
attendees who are likely to be at higher risk for
Chlamydia infection compared to the general
population.
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Open Access Researchothers. Clinical guidelines in Australia recommend
annual chlamydia testing in <25 year olds, annual HIV
and sexually transmissible infection (STI) testing for all
MSM and 3e6 monthly testing for high-risk MSM
reporting more than 10 sexual partners in the last
6 months, unprotected sex and other speciﬁc risk
behaviours.
8
Clinical risk prediction approaches that can capture
a continuous risk spectrum have been used in public
health and clinical care decision making and have been
proposed as an alternative to diagnosis for some diseases
in various contexts.
11 12 Our study aimed to develop and
validate a simple scoring tool to assess the risk of chla-
mydia infection using demographic and sexual risk
behaviour information collected from over 45000 indi-
viduals who attended Sydney Sexual Health Centre
(SSHC) between 1998 and 2009.
METHODS
Study population
The study population consists of 45902 men and women
who visited SSHC during the period 1998e2009. A
standard medical record form was used to collect
demographic and sexual behaviour information from all
new attendees and a sexual health screen was under-
taken. Since 1998 SSHC has actively triaged those at
higher risk of STIs into the service. SSHC also targets sex
workers from culturally and linguistically diverse
(CALD) backgrounds through interpreter facilitated sex
worker clinics.
For this analysis, the demographic and sexual behav-
iour information was extracted from the medical records
system including the anonymous patient identiﬁer, age,
gender, postcode, country of birth, date of arrival in
Australia (if born overseas), marital status, alcohol use,
condom use, number of male/female sex partners in the
last 3 and 12 months, sex overseas in the past 12 months,
reason for attendance, self-reported past chlamydia
diagnoses, perceived HIV status and the current HIV/
STI test results.
Statistical analyses
A split-sample method was used to develop a risk equa-
tion and scoring system with internal validation for each
study population. Participants were randomly allocated
to either the development (w67%) or internal valida-
tion (w33%) sample data sets within each group.
Development data set
Logistic regression was used to create a predictive model
basedonthedevelopmentdatasetwhichincluded11354,
6800 and 12700 MSM, heterosexual men and women,
respectively. We evaluated a range of socio-demographic
and sexual behaviour variables as potential determinants
of chlamydia infection including age, country of birth
(Australia vs other countries), language spoken at home
(English vs others), marital status (married/defacto vs
others(divorced/widowed/unknown)),CALD (not born
in Australia and not speaking English at home), travellers
(notborninAustraliaandinAustraliaforlessthan2 years
or those who identify themselves as ‘travellers’), area of
residence, alcohol use, number of sexual partners in the
past 3 months, condom use in the past 3 months, sex
overseas in the past year, current sex work, reason for
presentation, anal/genital symptoms, past chlamydia
diagnoses and perceived HIV status. All analyses were
stratiﬁed by sexual identity (MSM, heterosexual man or
woman).
We used descriptive statistics to characterise the
groups according to chlamydia status: mean and SD for
continuous variables and percentages for categorical
variables. Logistic regression was used to create
a predictive model based on the development data set.
We used all non-missing observations available in the
relevant analyses as only a small proportion of observa-
tions had any missing data. All analyses were conducted
using SAS statistical software v 9.2 (SAS Institute) and
STATA 10.0.
Derivation of a screening score
Using the development data sets for the three sub-
groups, we investigated a comprehensive list of predic-
tors known to be potentially associated with chlamydia
infection in an initial model. Speciﬁcally, we included
the main effects of all variables listed in table 1. We ﬁrst
analysed the univariate associations between each vari-
able and being diagnosed with STIs in each sub-group
separately. Backward elimination was used to reach the
ﬁnal multivariate model, in which factors with the largest
p value were sequentially deleted until only signiﬁcant
predictors remained. We then created a weighted
scoring system by rounding all regression coefﬁcients up
to the nearest integer (ie, the smallest integer greater
than the estimate). This method was based on the
b coefﬁcients (or log of the ORs) rather than ORs, which
can be excessively inﬂuenced by only a few factors.
11
Once the ﬁnal model was deﬁned, we created integer
weights for each variable. We calculated these weights by
multiplying the model coefﬁcients by 10. Using the
rounded weights in the risk function, we estimated the
participant-speciﬁc probabilities of chlamydia positivity
and characterised the degrees of risk based on cut-off
points of the probability distribution.
Cross-sectional internal validation
The prediction model was evaluated in the three cross-
sectional internal validation data sets of 3805 MSM, 5313
heterosexual men and 7084 women. We conducted
various analyses to check the sensitivity and robustness of
the new screening score. We computed standard valida-
tion measures for the proportion of those tested positive
for chlamydia infection, sensitivity, speciﬁcity, positive
likelihood and negative likelihood ratio and the area
underthereceiver-operatingcharacteristiccurve(AUC)
13
as discrimination statistics. Akaike information criteria
were evaluated as model ﬁt statistics. The Hosmere
Lemeshow goodness-of-ﬁt test was also performed. We
alsoassessedthediagnosticcharacteristicsofdifferentcut-
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Risk scoring tool for chlamydia infectionTable 1 Characteristics of the population
Characteristics
MSM,
N[10154
Heterosexual
male, N[16667
Heterosexual
female, N[19081
Age at visit, n (%)
<25 years 2179 (21) 4575 (27) 7516 (39)
25e29 years 2649 (26) 4851 (29) 5905 (31)
30e39 years 3342 (33) 4452 (27) 4175 (22)
40+ years 1984 (20) 2789 (17) 1485 (8)
Never been married 8408 (84) 12247 (75) 14520 (77)
Country of birth, n (%)
Australia 4986 (49) 6459 (39) 5735 (30)
England 1102 (11) 3108 (19) 2561 (13)
Asian countries* 498 (5) 339 (2) 1277 (7)
Missing 3568 (35) 6761 (41) 9508 (50)
Usually live in, n (%)
Metropolitan Sydney/eastern suburbs 6613 (65) 10258 (62) 10417 (57)
English spoken at home, n (%) 8781 (86) 14387 (86) 12922 (68)
Travellersy, n (%) 2775 (27) 6265 (38) 9766 (51)
CALDz, n (%) 1276 (13) 2155 (13) 6003 (31)
Employment status, n (%)
Employed 6737 (67) 10604 (65) 9173 (49)
Unemployed 1021 (10) 2210 (14) 2327 (12)
Student 1555 (16) 2118 (13) 4665 (25)
Current sex worker, n (%) 91 (1) 41 (<1) 3745 (20)
Current smoker, n (%) 2969 (29) 5096 (31) 6627 (35)
Excess alcoholx, n (%) 429 (4) 1453 (9) 2526 (13)
Injecting drug use ever, n (%) 723 (7) 630 (4) 595 (3)
Sex overseas (Asia) (last 12 months), n (%) 895 (9) 2320 (14) 1920 (10)
Inconsistent condom use (last 3 months), n (%) 3987 (40) 3389 (21) 3579 (19)
Male sex partners (last 3 months), n (%)
None 1193 (12) e 2855 (15)
One 2828 (28) e 11610 (61)
Two 1679 (17) e 3013 (16)
Three or more 7860 (78) e 1498 (7)
Female sex partners (last 3 months), n (%)
None e 1989 (12) e
One e 7642 (46) e
Two or more e 6913 (41) e
Reason for presentation, n (%)
HIV testing 1194 (12) 1154 (7) 843 (4)
STI test 3515 (35) 4131 (25) 6282 (33)
STI contact 568 (6) 796 (5) 761 (4)
Prophylaxis 305 (3) 29 (<1) 17 (<1)
Genital/anal symptoms, n (%) 3392 (33) 8998 (54) 7891 (41)
Past diagnosis, n (%)
Chlamydia 1450 (14) 2300 (14) 1796 (9)
Gonorrhoea 1587 (16) 659 (4) 264 (1)
Syphilis 365 (4) 84 (1) 71 (<1)
HPV 975 (10) 1777 (11) 1882 (10)
Genital herpes 481 (5) 629 (4) 1117 (6)
Not tested/not sure of HIV status, n (%) 2199 (22) 7894 (47) 9168 (48)
Current diagnosis, n (%)
Chlamydia 656 (6) 1124 (7) 973 (5)
Gonorrhoea 516 (5) 207 (1) 79 (<1)
Syphilis 109 (1) 10 (1) 12 (<1)
HPV 628 (6) 1623 (10) 1172 (6)
Genital herpes 183 (2) 594 (4) 749 (4)
HIV 113 (1) 11 (<1) 17 (<1)
*China (excludes SARs and Taiwan), Indonesia, South Korea, Malaysia, Philippines, Singapore and Thailand.
yBorn outside Australia and arrived in Australia in last 2 years.
zBorn outside Australia and does not speak English at home.
xAverage alcohol intake of 280 g for men and 140 g for women per week.
CALD, culturally and linguistically diverse; HPV, human papillomavirus; MSM, men who have sex with men; STI, sexually transmissible infection.
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Risk scoring tool for chlamydia infectionpoints based on the total score in the development as well
asthevalidation datasets.Thepurpose ofthisanalysiswas
to assess whether the combination of risk factors under
consideration could predict those at increased risk with
acceptable accuracy.
Population attributable risk
We then estimated the population attributable risk
(PAR), which estimates the percentage of chlamydia
infections that would not have occurred if all the
participants had been in the lowest risk (ﬁrst quintile)
category of the risk score. We calculated PAR by using
previously described methods
14 that were elaborated for
this study design and are appropriate for use with
multivariate adjusted relative risks.
Ethics approval for the study was obtained from the
South Eastern Sydney and Illawarra Area Health Service
Human Research Ethics Committee.
RESULTS
Table 1 summarises participant characteristics by group.
The overall prevalence of chlamydia was 6%, 7% and 5%
for MSM, heterosexual men and women, respectively.
MSM were more likely to be Australian born and live in
metropolitan Sydney. More than 30% of the females were
from CALD backgrounds compared to 13% of hetero-
sexual men and MSM. Approximately 50% of females
were also classiﬁed as travellers compared to 38% and
27% of heterosexual men and MSM, respectively.
Althoughexcess alcohol intakeand current smokerswere
more common among heterosexual men and women
compared to MSM, more MSM reported ever injecting
drug use. Approximately 50% of women reported being
in full time employment and 20% of them identiﬁed as
being a sex worker. More heterosexual men reported that
they had had sex in Asia in the last 12 months. Inconsis-
tent condom use in the last 3 months and presenting with
genital or anal symptoms were more common among
heterosexual men and women compared to MSM. The
primary reason for making an appointment was testing
for STI in all groups, however, presentation for HIV
testing was more common among MSM compared to
heterosexual men and women. Consistent with this,
approximately 50% of heterosexual men and women also
did not know their HIV status compared to 22% of MSM.
Prediction model
Table 2 presents the ﬁnal multivariate logistic regression
model derived from the development data set for each
group. Independent predictors of chlamydia infection in
MSM were younger age, inconsistent condom use,
increased number of male sexual partners in the past
3 months, anal/genital symptoms and presenting for STI
screening or being a contact of an STI case.
Independent predictors of chlamydia infection in
heterosexual men were being single, CALD background,
being unsure about HIV status, inconsistent condom
use, increased number of female sexual partners in the
past 3 months, anal/genital symptoms and presenting
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Risk scoring tool for chlamydia infectionfor STI screening or being a contact of an STI case. The
HosmereLemeshow goodness-of-ﬁt test showed no lack
of ﬁt for the three ﬁtted models (p>0.21 in all models).
Independent predictors of chlamydia infection in
women were being single, CALD background, being
unsure about HIV status, inconsistent condom use,
anal/genital symptoms, presenting for STI screening or
being a contact of an STI case.
Internal validation
The variables age and number of male/female sexual
partners required multiple categories to capture the risk
gradient, whereas other risk factors were binary. The risk
factors collectively yielded an AUC of 0.71 (95% CI 0.69
to 0.73) for MSM, 0.74 (95% CI 0.72 to 0.75) for hetero-
sexual men and 0.72 (95% CI 0.70 to 0.74) for women.
No statistically signiﬁcant interactions were detected
between the sexual risk factors and the age groups.
Table 3 shows the odds ratios from the logistic
regression models for the quintiles of the risk scores in
the development and validation data sets. The ORs (95%
CI) of chlamydia positivity for participants in successively
higher quintiles of STI score were: 1.79 (1.23 to 2.60),
2.96 (2.10 to 4.15), 4.56 (3.30 to 6.30) and 8.80 (6.43 to
12.02) for MSM; 2.53 (1.76 to 3.63), 4.21 (2.97 to 5.98),
6.82 (4.84 to 9.60) and 14.17 (10.20 to 19.68) for
heterosexual men; and 2.50 (1.67 to 3.76), 3.70 (2.51 to
5.43), 4.59 (3.11 to 6.78) and 12.33 (8.55 to 17.78) for
heterosexual women. There was a linear trend towards
increasing chlamydia positivity with increasing score
regardless of group for the development and validation
data sets (trend, p value<0.001, all).
We also estimated PARs (95% CI) for the upper four
quintiles of the scores. Results showed that 73% (69% to
76%) of infections in MSM, 80% (77% to 82%) of
infections in heterosexual men and 78% (74% to 81%) of
infections in women would be avoided if the participants
who were in the upper four quintiles of the STI scores
were in the lowest quintile. Results from the validation
data set were consistent with results from the develop-
ment data set.
We performed additional analyses to assess the diag-
nostic characteristics of various cut-points of the total
score in the overall study population (table 4). For
example, among heterosexual men, the predictive value
of the screening criteria for a cut-point score of 20 or
higher was approximately 10%. Although it is crucial to
determine the best cut-point to alert those at highest risk
for infection, a cut-point of $20 or higher demonstrated
excellent sensitivity among MSM and heterosexual
males (80.0% and 96.8%, respectively) and acceptable
sensitivity among heterosexual women (70.0%).
DISCUSSION
In this study, we have developed a chlamydia risk scoring
tool based on data from more than 45000 men and
Table 3 ORs and 95% CIs for being diagnosed with chlamydia infection by quintiles of chlamydia risk scoring
MSM Heterosexual males Heterosexual females
OR (95% CI) p Value* OR (95% CI) p Value* OR (95% CI) p Value*
Development data set
Chlamydia risk scorey
1st Quintile 1 <0.001 1 <0.001 1 <0.001
2nd Quintile 1.79 (1.23 to 2.60) 2.53 (1.76 to 3.63) 2.50 (1.67 to 3.76)
3rd Quintile 2.96 (2.10 to 4.15) 4.21 (2.97 to 5.98) 3.70 (2.51 to 5.43)
4th Quintile 4.56 (3.30 to 6.30) 6.82 (4.84 to 9.60) 4.59 (3.11 to 6.78)
5th Quintile 8.80 (6.43 to 12.02) 14.17 (10.20 to 19.68) 12.33 (8.55 to 17.78)
AUC (95% CI) 0.75 (0.72 to 0.76) 0.72 (0.70 to 0.73) 0.73 (0.70 to 0.74)
Population attributable risk for chlamydia risk score (%)z (95% CI)
Lowest vs upper
four quintiles
73% (0.69 to 0.76) 80% (0.77 to 0.82) 78% (0.74 to 0.81)
Validation data set
Chlamydia risk scorey
1st Quintile 1 <0.001 1 <0.001 1 <0.001
2nd Quintile 1.80 (1.17 to 2.75) 2.40 (1.30 to 4.42) 1.62 (1.01 to 2.59)
3rd Quintile 2.29 (1.54 to 3.40) 4.67 (2.64 to 8.27) 2.80 (1.82 to 4.29)
4th Quintile 3.93 (2.70 to 5.73) 6.81 (3.88 to 11.95) 4.07 (2.66 to 6.24)
5th Quintile 6.57 (4.52 to 9.54) 12.71 (7.37 to 21.90) 8.10 (5.34 to 12.20)
AUC (95% CI) 0.74 (0.72 to 0.75) 0.71 (0.69 to 0.73) 0.72 (0.70 to 0.74)
Population attributable risk for chlamydia risk score (%) (95% CI)
Lowest vs upper
four quintiles
67% (0.62 to 0.72) 84% (0.81 to 0.87) 68% (0.63 to 0.74)
*Test for trend.
yChlamydia risk score was as follows: for heterosexual males (median: 26) <20 for 1st quintile, 20e25 for 2nd quintile, 26e30 for 3rd quintile,
31e35 for 4th quintile and 36+ for 5th quintile; for MSM (median: 20) <15 for 1st quintile, 15e18 for 2nd quintile, 19e22 for 3rd quintile, 23e27
for 4th quintile and 28+ for 5th quintile; and for females (median: 27) <13 for 1st quintile, 13e16 for 2nd quintile, 17e20 for 3rd quintile, 21e24
for 4th quintile and 25+ for 5th quintile.
AUC, area under the curve; MSM, men who have sex with men.
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Risk scoring tool for chlamydia infectionwomen who attended SSHC during the period
1998e2009. The tool was validated to accurately identify
those at increased risk of chlamydia infection. Our
methodology made use of a range of coexisting risk
factors that were identiﬁed by a rigorous statistical
approach in order to accurately determine the most
relevant risk factors for chlamydia infection.
Developing a risk assessment tool that identiﬁes,
quantiﬁes and characterises risks may lead to improved
knowledge about chlamydia and increased testing for
STIs. This is particularly relevant because many infec-
tions are asymptomatic and individuals may be unaware
that they are at risk and/or have the infection. For
example, our current study found higher percentages of
heterosexual males and females were unsure of their
HIV status compared to MSM (47%, 48% and 22%
for heterosexual men, women and MSM, respectively)
and those who were not aware of their HIV status
were determined to be at high risk for chlamydia infec-
tion (OR 1.38, p¼0.001 and OR 1.54, p<0.001 for
heterosexual men and women, respectively).
This study has several strengths. It is the ﬁrst study to
utilise statistical methods to derive a locally-speciﬁc risk
assessment tool to identify, quantify and characterise
the risks of various groups in Australia with acceptable
sensitivity. Risk assessment methods or prediction
models ideally should be derived from large represen-
tative samples. Our study used 12 years of data from
more than 45000 men and women to develop the
suggested risk assessment tool. Our risk calculation was
based on a statistical method that yielded a systematic
scoring system for carefully selected predictors, guided
by both scientiﬁc evidence and feasibility perspectives.
However, our study is limited by its retrospective nature
and the self-reported measures of the sexual risk factors
and anal/genital symptoms which may be subject to
measurement error/misclassiﬁcation. The study popu-
lation was based on clinic attendees who are triaged
into the service based on risk assessment and/or the
presence of symptoms as demonstrated by the positivity
of 6%, 7% and 5% for MSM, heterosexual men and
women, respectively. When we restricted the analyses to
those younger than 20 years of age, chlamydia positivity
rates were estimated to be 11%, 8% and 7% for MSM,
heterosexual male and females, respectively, compared
to 3%e5% among young MSM, heterosexual men and
w o m e ni nc o m m u n i t y - b a s e ds t u d i e s .
8 It is also possible
that chlamydia infection might have been acquired
prior to the sexual risk behaviour that preceded the
clinic visit as chlamydia infection can persist for an
average of 12 months if untreated.
9 Finally, risk
prediction models apply primarily to groups deﬁned by
a set of clinically relevant variables rather than directly
to individuals. This is a limitation common to all risk
prediction models.
10 Indeed, prevention of chlamydia
infection may require population-based interventions
that are beyond the control of individual physicians and
patients. Therefore, our risk prediction assessment
serves only as a guideline and should not be taken as an
absolute deﬁnition of high risk.
We envisage that the chlamydia risk scoring tool
developed in this study will be adapted for interactive
clinic websites and the interface and website will be
designed and calibrated for use by relevant populations
including people from CALD backgrounds who were at
higher risk for chlamydia infection. The screening tool
will also be piloted in primary care clinics targeting those
at higher risk for infection(s).
In conclusion, we believe the screening tool described
here will provide a simple and cost-effective method of
identifying and alerting individuals who would beneﬁt
from chlamydia screening with notable predictive
validity. Self-identiﬁcation, if widely practiced, could be
an effective method of case ascertainment and may
encourage uptake of screening.
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